Filing Details

Accession Number:
0001125345-22-000075
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-17 16:18:36
Reporting Period:
2022-06-15
Accepted Time:
2022-06-17 16:18:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587477 James Karrels 9704 Medical Center Drive
Rockville MD 20850
Svp, Cfo And Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-06-15 40,000 $2.47 191,776 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $2.435 to $2.50. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
  2. Owned jointly with reporting person's wife.